Follow us on:

Why is the outlook for Goodbody Health ‘tremendously exciting and hugely positive’ (VIDEO)

Goodbody Health Inc. (CSE: GBDY / AQSE: GBDY / FRA: 484 / OTC: SCNNF) CEO Marc Howells joins DirectorsTalk Interviews to discuss a change of name and direction for the company.

Marc shares his views on a under resourced and over burdened NHS, a change in how people manage their health, how Goodbody Health is meeting the massive growing demand for its services and can the company continue to grow at such speed.

Goodbody Health Inc. (CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF) are a wellness company, focusing on the Health and Wellness of customers through the local community by the introduction and use of cutting edge diagnostic equipment.

Disrupting the ‘old model’ of courier to laboratory style testing.

Goodbody Health (CSE: GBDY / AQSE: GBDY / FRA: 484 / OTC: SCNNF ) is the parent company for its main brand name “Goodbody” and its trading subsidiaries “Goodbody Wellness Limited” and “Goodbody Botanicals Ltd”

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

More News

Weight loss support now available in high street pharmacies January 24, 2022
High cholesterol – Blood testing crucial to avoid health complications January 21, 2022
Goodbody Health plays key testing role as UK Covid rules change January 18, 2022
This week: TomCo Energy, Dekel Agri-Vision, Goodbody Health, Kenmare Resources and PetroNeft Resources January 14, 2022
Sativa Wellness Group changes name to Goodbody Health Inc with clear strategic direction January 10, 2022

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.